Enrique Alvarez

基本信息

浏览量：1

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 272 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Ublituximab Significantly Reduces Radiological Disease Activity at 12 Weeks: Post-hoc Analysis of Participants with Highly Active Disease in the ULTIMATE I & II Phase 3 Studies (P9-6.017)

Derrick Robertson,Hans-Peter Hartung,Douglas Arnold,Lily Lee,Anne Gocke,Koby Mok,Enrique Alvarez

Neurology（2024）

引用0浏览0引用

Neurologic Outcomes in People with Multiple Sclerosis Treated with Immune Checkpoint Inhibitors for Oncologic Indications

Carson M Quinn, Prashanth Rajarajan,Alexander J Gill, Hannah Kopinsky,Andrew B Wolf, Celeste Soares de Camargo,Jessica Lamb,Tamar E Bacon,Joseph C Murray,John C Probasco,Kristin M Galetta,Daniel Kantor,Patricia Coyle,Vikram Bhise,Enrique Alvarez,Sarah E Conway,Shamik Bhattacharyya,Ilya Kister

Neurologyno. 11 (2024): e210003-e210003

引用0浏览0WOS引用

Feasibility of Low-Load Resistance Training Using Blood Flow Restriction for People with Advanced Multiple Sclerosis: A Prospective Cohort Study

Mark M Mañago,Evan T Cohen,Enrique Alvarez,Emily R Hager,Johnny G Owens,Michael Bade

Physical therapyno. 1 (2024)

引用0浏览0WOS引用

Senescent-like Microglia Limit Remyelination Through the Senescence Associated Secretory Phenotype

Phillip S Gross,Violeta Duran Laforet,Zeeba Manavi,Sameera Zia, Sung Hyun Lee,Nataliia Shults,Sean Selva,Enrique Alvarez,Jason R Plemel,Dorothy P Schafer,Jeffrey K Huang

bioRxiv the preprint server for biology (2024)

引用0浏览0WOS引用

Baseline Serum Neurofilament Light Chain Levels Predict Future Disease Activity Irrespective of Race/Ethnicity: Results from the Phase 3 ASCLEPIOS I/II Trials (P9-6.006)

Jason Freeman,Silvia Delgado,Enrique Álvarez,Éric Thouvenot,Annette Okai,Alit Bhatt, Wenqi Wei,Tjalf Ziemssen

Neurologyno. 17_supplement_1 (2024)

引用0浏览0引用

Prognostic Value of Serum Neurofilament Light Chain for Disease Activity in Patients with Relapsing Multiple Sclerosis: Results from Subgroup Analysis Based on Body Mass Index and Age from the Phase 3 ASCLEPIOS I/II Trials (P6-6.011)

Anne Cross,Tjalf Ziemssen,Douglas Arnold,Eric Thouvenot,Scott Zamvil,Alit Bhatt, Wenjia Wei,Ibolya Boer,Enrique Alvarez,Heinz Wiendl

Neurology（2024）

引用0浏览0引用

Baseline Serum Neurofilament Light Chain Levels Predict Future Disease Activity Irrespective of Race/Ethnicity: Results from the Phase 3 ASCLEPIOS I/II Trials (P9-6.006)

Jason Freeman,Silvia Delgado,Enrique Alvarez,Eric Thouvenot,Annette Okai,Alit Bhatt, Wenjia Wei,Tjalf Ziemssen

Neurologyno. 17_supplement_1 (2024)

引用0浏览0引用

Multi-institutional Study of Neurologic Outcomes in People with Multiple Sclerosis Who Are Treated with Immune Checkpoint Inhibitors for Oncologic Indications (PL4.004)

Carson Quinn, Prashanth Rajarajan, Hannah Kopinsky,Andrew Wolf, Celeste Soares De Camargo,Alexander Gill,Joseph Murray,John Probasco,Kristin Galetta,Daniel Kantor,Patricia Coyle,Vikram Bhise,Enrique Alvarez,Sarah Conway,Shamik Bhattacharyya,Ilya Kister

Neurology（2024）

引用0浏览0引用

Immunoglobulin Level Changes in Patients with Multiple Sclerosis Treated with Anti-CD20 Monoclonal Antibodies (P9-6.011)

Brandi Vollmer, Timber Bourassa, Erin Marsh, Vi Dao,Abhijit Gadkari,Brandon Brown,Stefan Sillau,Kavita Nair,Enrique Alvarez

Neurology（2024）

引用0浏览0引用

Improvements in No Evidence of Disease Activity with Ublituximab Vs. Teriflunomide in the ULTIMATE Phase 3 Studies in Relapsing Multiple Sclerosis

Enrique Alvarez,Lawrence Steinman, Edward J Fox,Hans-Peter Hartung, Peiqing Qian,Sibyl Wray,Derrick Robertson,Krzysztof Selmaj,Daniel Wynn,Koby Mok, Yihuan Xu, Karthik Bodhinathan, Hari P Miskin, Bruce A C Cree

Frontiers in neurology（2024）

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

副教授

论文共 272 篇作者统计合作学者相似作者